Why Mersana’s Cancer Study Is Huge
Mersana Therapeutics shares jumped on Wednesday after the company reported interim results from its early-stage cancer study.
All Work
Chris Lange
Chesapeake Energy Stock’s Summer of Doom and Gloom
The reopening of the U.S. economy may not save Chesapeake Energy as oil prices remain weak and the company’s finances look bleak.
Gates Foundation Likely to Be Rewarded for Apple Stock Buy
The Gates Foundation recently joined Warren Buffett and lots of other investors as holders of Apple stock.
Diffusion Pharma’s COVID-19 Treatment Takes a Big Step Forward With the FDA
Diffusion Pharmaceuticals shares pushed higher to start the week after it announced a critical update from the FDA concerning its potential treatment for COVID-19 patients displaying severe respiratory symptoms and low oxygen levels.
Meet Merck’s Newest Collaborations in the Fight Against COVID-19
Merck shares jumped on Tuesday after the company announced that it has made deals to develop drugs in the fight against COVID-19.
Why the Novavax Vaccine Update Is Huge
Novavax shares jumped to start off the week after an update from its COVID-19 vaccine trial. This news adds to investor optimism and is helping to lift the broad markets in general.
Is AutoZone Poised for New Highs After Earnings?
AutoZone reported better than expected fiscal third-quarter financial results before the markets opened on Tuesday.
Costco, Dollar General, Dollar Tree, HP, Salesforce and Others Reporting This Week
24/7 Wall St. takes a look at Costco, Salesforce and some of the other key companies reporting quarterly results in this truncated trading week.
Will E-Commerce Shops Deliver a Boost for Facebook Stock?
Facebook’s Shops feature will leverage the social network’s huge user base and create new competition for Amazon.
Amarin Stock’s Potential Unhampered by Generic Approval
Amarin will trial Vascepa as a COVID-19 treatment and that could more than offset investor concerns about patent litigation.
Why This Rheumatoid Arthritis Study Is Huge for Navidea Biopharma
Navidea Biopharmaceuticals shares more than doubled to close out the week after the company provided an update from its midstage study in patients with active rheumatoid arthritis.
How XpresSpa Is Capitalizing on the Fight Against COVID-19
XpresSpa shares jumped as the week wound down after the company gave an update on its COVID-19 efforts on Friday.
Is Alibaba’s Bottom Line Beat Enough for Investors?
Alibaba released better than expected fiscal fourth-quarter financial results before the markets opened on Friday.
Why Analysts Are Mixed on Beyond Meat Stock
Beyond Meat’s stock has had a huge rally but the company needs new sales channels and price parity with traditional meat.
What to Expect When Alibaba Reports Friday Morning
Alibaba is scheduled to report its most recent quarterly results before the markets open on Friday. Analysts expect strong topline growth year over year.
Can Nvidia Keep Up the Pace With Q1 Earnings?
Analysts are looking for strong year-on-year growth when reports its fiscal first-quarter financial results after the markets close on Thursday.
How Competition Affects (or Doesn’t) Amazon Stock
Can Amazon be stopped? The coronavirus has been good for business, its stock is at all-time highs, and its product offerings and revenues keep growing.
Why Best Buy’s Q1 Fell Short
Retailer Best Buy released better than expected fiscal first-quarter financial results before the markets opened on Thursday.
Why Apple Stock Is Having a V-Shaped Recovery
Apple is reopening stores globally, its products and services haven’t lost any popularity in the pandemic, and it’s sitting on a huge pile of cash.
Wil Regulatory Burdens Push Luckin Coffee Stock to Zero?
Luckin Coffee has resumed trading but the stock immediately plummeted. With the prospect of delisting from the Nasdaq, this stock could very well be on its way to zero.